A detailed history of Pegasus Partners Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Pegasus Partners Ltd. holds 2,069 shares of MRK stock, worth $205,203. This represents 0.02% of its overall portfolio holdings.

Number of Shares
2,069
Previous 2,069 -0.0%
Holding current value
$205,203
Previous $256,000 8.59%
% of portfolio
0.02%
Previous 0.03%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$113.24 - $131.95 $33,632 - $39,189
-297 Reduced 12.55%
2,069 $273,000
Q4 2023

Feb 12, 2024

BUY
$100.18 - $109.02 $42,175 - $45,897
421 Added 21.65%
2,366 $257,000
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $200,237 - $222,371
1,945 New
1,945 $200,000
Q2 2022

Aug 12, 2022

BUY
$83.49 - $94.64 $21,289 - $24,133
255 Added 9.82%
2,852 $260,000
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $190,905 - $213,992
2,597 New
2,597 $213,000
Q4 2021

Feb 09, 2022

SELL
$72.28 - $90.54 $208,310 - $260,936
-2,882 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $63,866 - $70,237
-891 Reduced 23.62%
2,882 $216,000
Q2 2021

Aug 13, 2021

SELL
$70.31 - $77.77 $178,517 - $197,458
-2,539 Reduced 40.22%
3,773 $293,000
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $274,544 - $323,385
-3,987 Reduced 38.71%
6,312 $487,000
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $114,401 - $126,962
1,594 Added 18.31%
10,299 $842,000
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $4,829 - $5,474
-66 Reduced 0.75%
8,705 $722,000
Q2 2020

Aug 12, 2020

BUY
$70.42 - $80.13 $191,260 - $217,633
2,716 Added 44.86%
8,771 $678,000
Q1 2020

May 11, 2020

BUY
$63.36 - $87.82 $175,190 - $242,822
2,765 Added 84.04%
6,055 $466,000
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $255,238 - $288,006
3,290 New
3,290 $299,000
Q4 2017

Feb 08, 2018

SELL
$51.62 - $61.64 $682,519 - $815,004
-13,222 Closed
0 $0
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $775,734 - $834,704
13,222
13,222 $847,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Pegasus Partners Ltd. Portfolio

Follow Pegasus Partners Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Pegasus Partners Ltd. with notifications on news.